PBH
Prestige Consumer Healthcare Inc
Price:  
63.82 
USD
Volume:  
562,332.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PBH Relative Valuation

101.3%
Upside

As of 2025-09-18, the Relative Valuation of Prestige Consumer Healthcare Inc (PBH) is 128.50 USD. This relative valuation is based on P/E multiples. With the latest stock price at 63.82 USD, the upside of Prestige Consumer Healthcare Inc based on Relative Valuation is 101.3%.

The range of the Relative Valuation is 100.97 - 149.42 USD.

Range Selected
Trailing P/E multiples 25.5x - 34.5x 30.8x
Forward P/E multiples 23.9x - 34.3x 29.3x
Fair Price 100.97 - 149.42 128.50
Upside 58.2% - 134.1% 101.3%
63.82 USD
Stock Price
128.50 USD
Fair Price

PBH Relative Valuation - Historical P/E Data

Date P/E
2025-09-16 14.60
2025-09-15 14.55
2025-09-12 14.61
2025-09-11 15.02
2025-09-10 15.03
2025-09-09 15.25
2025-09-08 15.20
2025-09-05 15.03
2025-09-04 15.42
2025-09-03 15.46
2025-09-02 15.36
2025-08-29 15.72
2025-08-28 15.54
2025-08-27 15.47
2025-08-26 15.34
2025-08-25 15.17
2025-08-22 15.41
2025-08-21 15.12
2025-08-20 15.03
2025-08-19 15.11
2025-08-18 14.99
2025-08-15 15.01
2025-08-14 14.92
2025-08-13 15.35
2025-08-12 15.09
2025-08-11 14.76
2025-08-08 15.15
2025-08-07 15.62
2025-08-06 17.36
2025-08-05 17.11
2025-08-04 17.14
2025-08-01 17.03
2025-07-31 17.08
2025-07-30 17.36
2025-07-29 17.25
2025-07-28 17.63
2025-07-25 17.76
2025-07-24 17.62
2025-07-23 17.73
2025-07-22 17.65
2025-07-21 17.46
2025-07-18 17.51
2025-07-17 17.36
2025-07-16 17.37
2025-07-15 17.36
2025-07-14 17.66
2025-07-11 17.67
2025-07-10 17.91
2025-07-09 18.22
2025-07-08 18.16